Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
everolimus (zortress) (1 trial)
niraparib (zejula) (1 trial)
paclitaxel (taxol) (1 trial)
sapanisertib (1 trial)
tak-117 (1 trial)
Breast Neoplasms (Phase 1)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (5 total)